Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo

NeuroImage

Volumn 111, Issue , 2015, Pages 186-191

  Hall, Mei Hua ^a   Jensen, J Eric ^a   Du, Fei ^a   Smoller, Jordan W ^b   O'Connor, Lauren ^a   Spencer, Kevin M ^c   Öngür, Dost ^a  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Event related potential; Glutamate; Magnetic resonance spectroscopy (MRS); P3

Indexed keywords

GLUTAMIC ACID; GLUTAMINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; AUDITORY RESPONSE; BRAIN LEVEL; EVENT RELATED POTENTIAL; FEMALE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MENTAL TASK; NORMAL HUMAN; PARIETAL LOBE; PARIETAL OCCIPITAL CORTEX; PARIETO-OCCIPITAL SULCUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TASK PERFORMANCE; AUDITORY EVOKED POTENTIAL; CINGULATE GYRUS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; FRONTAL LOBE; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; YOUNG ADULT;

EID: 84923542046     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.02.014     Document Type: Article

References (41)

1. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. Acad. Sci. 1987, 508:333-348.
2. Brennan B.P., Hudson J.I., Jensen J.E., McCarthy J., Roberts J.L., Prescot A.P., Cohen B.M., Pope H.G., Renshaw P.F., Ongur D. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 2010, 35:834-846.
3. Bustillo J.R., Chen H., Jones T., Lemke N., Abbott C., Qualls C., Canive J., Gasparovic C. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3T. JAMA Psychiatry 2014, 71:265-272.
4. Carter C.S., Mintun M., Nichols T., Cohen J.D. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am. J. Psychiatry 1997, 154:1670-1675.
5. Coyle J.T. NMDA receptor and schizophrenia: a brief history. Schizophr. Bull. 2012, 38:920-926.
6. Dien J., Spencer K.M., Donchin E. Localization of the event-related potential novelty response as defined by principal components analysis. Brain Res. Cogn. Brain Res. 2003, 17:637-650.
7. Dien J., Spencer K.M., Donchin E. Parsing the late positive complex: mental chronometry and the ERP components that inhabit the neighborhood of the P300. Psychophysiology 2004, 41:665-678.
8. Donchin E., Coles M.G.H. Is the P300 component a manifestation of context updating. Behav. Brain Sci. 1988, 11:357-374.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID): New York 1997, New York State Psychiatric Institute, Biometrics Research, New York.
10. Fowler B., Mitchell I. Biological determinants of P300: the effects of a barbiturate on latency and amplitude. Biol. Psychol. 1997, 46:113-124.
11. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci. Biobehav. Rev. 2001, 25:355-373.
12. Gallinat J., Kunz D., Senkowski D., Kienast T., Seifert F., Schubert F., Heinz A. Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing. Psychopharmacology 2006, 187:103-111.
13. Ghoddoussi F., Galloway M.P., Jambekar A., Bame M., Needleman R., Brusilow W.S. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J. Neurol. Sci. 2010, 290:41-47.
14. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 1983, 55:468-484.
15. Gunduz-Bruce H., Reinhart R.M., Roach B.J., Gueorguieva R., Oliver S., D'Souza D.C., Ford J.M., Krystal J.H., Mathalon D.H. Glutamatergic modulation of auditory information processing in the human brain. Biol. Psychiatry 2012, 71:969-977.
16. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr. Clin. Neurophysiol. 1998, 106:156-164.
17. Hall M.H., Schulze K., Rijsdijk F., Kalidindi S., McDonald C., Bramon E., Murray R.M., Sham P. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol. Med. 2009, 39:1277-1287.
18. Igarashi H., Kwee I.L., Nakada T., Katayama Y., Terashi A. 1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: longitudinal metabolic changes in ischemic core and rim. Brain Res. 2001, 907:208-221.
19. Iltis I., Koski D.M., Eberly L.E., Nelson C.D., Deelchand D.K., Valette J., Ugurbil K., Lim K.O., Henry P.G. Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study. NMR Biomed. 2009, 22:737-744.
20. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nat. Rev. Drug Discov. 2008, 7:68-83.
21. Jensen J.E., Licata S.C., Ongur D., Friedman S.D., Prescot A.P., Henry M.E., Renshaw P.F. Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. NMR Biomed. 2009, 22:762-769.
22. Kayser J., Tenke C.E. Principal components analysis of Laplacian waveforms as a generic method for identifying ERP generator patterns: II. Adequacy of low-density estimates. Clin. Neurophysiol. 2006, 117:369-380.
23. Knight R.T., Scabini D., Woods D.L., Clayworth C.C. Contributions of temporal-parietal junction to the human auditory P3. Brain Res. 1989, 502:109-116.
24. Lally N., Mullins P.G., Roberts M.V., Price D., Gruber T., Haenschel C. Glutamatergic correlates of gamma-band oscillatory activity during cognition: a concurrent ER-MRS and EEG study. Neuroimage 2014, 85(Pt 2):823-833.
25. Marsman A., van den Heuvel M.P., Klomp D.W., Kahn R.S., Luijten P.R., Hulshoff Pol H.E. Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies. Schizophr. Bull. 2013, 39:120-129.
26. Mathalon D.H., Ford J.M., Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol. Psychiatry 2000, 47:434-449.
27. Mlynarik V., Kohler I., Gambarota G., Vaslin A., Clarke P.G., Gruetter R. Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra-short echo times. Magn. Reson. Med. 2008, 59:52-58.
28. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
29. Nieuwenhuis S., Aston-Jones G., Cohen J.D. Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol. Bull. 2005, 131:510-532.
30. Ongur D., Jensen J.E., Prescot A.P., Stork C., Lundy M., Cohen B.M., Renshaw P.F. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol. Psychiatry 2008, 64:718-726.
31. Oranje B., van Berckel B.N., Kemner C., van Ree J.M., Kahn R.S., Verbaten M.N. The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 2000, 22:293-302.
32. Pellerin L., Magistretti P.J. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 2004, 10:53-62.
33. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007, 118:2128-2148.
34. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. Int. J. Psychophysiol. 2006, 60:172-185.
35. Posse S., Otazo R., Caprihan A., Bustillo J., Chen H., Henry P.G., Marjanska M., Gasparovic C., Zuo C., Magnotta V., Mueller B., Mullins P., Renshaw P., Ugurbil K., Lim K.O., Alger J.R. Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4Tesla. Magn. Reson. Med. 2007, 58:236-244.
36. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001, 14:260-264.
37. Schousboe A., Waagepetersen H.S. Role of astrocytes in glutamate homeostasis: implications for excitotoxicity. Neurotox. Res. 2005, 8:221-225.
38. Spencer K.M., Dien J., Donchin E. Spatiotemporal analysis of the late ERP responses to deviant stimuli. Psychophysiology 2001, 38:343-358.
39. Turner J.A., Damaraju E., van Erp T.G., Mathalon D.H., Ford J.M., Voyvodic J., Mueller B.A., Belger A., Bustillo J., McEwen S., Potkin S.G., Fbirn, Calhoun V.D. A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front. Neurosci. 2013, 7:137.
40. Watson T.D., Petrakis I.L., Edgecombe J., Perrino A., Krystal J.H., Mathalon D.H. Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. Int. J. Neuropsychopharmacol. 2009, 12:357-370.
41. Xu S., Yang J., Li C.Q., Zhu W., Shen J. Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by 1H MRS at 11.7T. Neuroimage 2005, 28:401-409.